期刊文献+

不同血液净化方式对维持性血液透析患者成纤维细胞生长因子-23清除效果的研究

Research on clearance of fibroblast growth factor-23 of maintenance hemodialysis patients by different blood purification methods
原文传递
导出
摘要 目的探讨不同血液净化方式对维持性血液透析(MHD)患者成纤维细胞生长因子-23(FGF-23)的清除效果。方法选取MHD患者120例为研究对象,随机分为低通量透析组(HD)、血液透析滤过组(HDF)、高通量透析组(HFHD),每组40例,治疗6个月,分别检测治疗前后血钙(Ca)、血磷(P)、碱性磷酸酶(ALP)、甲状旁腺素(PTH)、FGF-23水平的变化。结果 (1)三组患者治疗前后血Ca水平差异均无统计学意义(P>0.05);(2)HD组治疗前后血P、ALP、PTH、FGF-23水平差异均无统计学意义(P>0.05),HDF组和HFHD组治疗后血P、ALP、PTH、FGF-23水平与治疗前相比均明显下降(P<0.05),与HDF组相比,HFHD组PTH和FGF-23水平下降更明显(P<0.05)。结论与HD及HDF相比,HFHD能更有效清除FGF-23,降低MHD患者肾性骨病发生率。 Objective To analyse the clearance effects of fibroblast growth factor - 23 ( FGF - 23 ) of maintenance hemo- dialysis(MHD) patients by different blood purification methods. Methods Totally 120 MHD patients were selected and divided into three groups : hemodialysis ( HD ), hemodlafihration (HDF) and high flux hemodialysis ( HFHD ). There were 40 patients in each group. Patients in every group were treated by different blood purification methods for six months. Calcium, phosphorus, alkaline phosphatase(ALP), parathyroid hormone(PTH), FGF-23 were detected be- fore and after six months of treatment. Results ①There was no significant difference of Calcium before and after treat- ment in each group( P 〉 0. 05 ) ; ②There was no significant difference of phosphorus, ALP, PTH and FGF - 23 before and after treatment in HD group( P 〉0. 05 ) ; After six months of treatment, phosphorus, ALP, PTH and FGF - 23 were significant decreased in HDF and HFHD group compared with pre - treatment ; PTH and FGF - 23 in HFHD group were lower than that in HDF group after treatment (P 〈 0. 05 ). Conclusion Compared with HD and HDF, HFHD can clear FGF -23 more effectively, and may play a role in decreasing occurrence rate of renal osteopathy.
出处 《医药论坛杂志》 2016年第11期17-19,共3页 Journal of Medical Forum
基金 郑州市科技局普通攻关项目(20130579)
关键词 血液透析 血液透析滤过 高通量血液透析 成纤维细胞生长因子-23 Hemodialysis Hemodiafiltration High - flux hemodialysis Fibroblast Growth Factor - 23
  • 相关文献

参考文献2

二级参考文献15

  • 1邵素荣,张建荣.FGF-23在继发性甲状旁腺功能亢进症发病机制中的作用进展[J].中国血液净化,2012,11(7):392-395. 被引量:8
  • 2Neil Thompson,John Lyons.Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery[J].Current Opinion in Pharmacology.2005(4)
  • 3Thomas Force,Joseph V. Bonventre.Growth Factors and Mitogen-Activated Protein Kinases[J].Hypertension ( Suppl to Hyper).1998(2SuppltoHyper)
  • 4O Moranne,M Froissart,J Rossert,C Gauci,JJ Boffa,JP Haymann,MB M’rad,C Jacquot,P Houillier,B Stengel,B Fouqueray,NephroTest Study Group.Timing of onset of CKD-related metabolic complications[].Journal of the American Society of Nephrology : JASN.2009
  • 5Itaru Urakawa,Yuji Yamazaki,Takashi Shimada,Kousuke Iijima,Hisashi Hasegawa,Katsuya Okawa,Toshiro Fujita,Seiji Fukumoto,Takeyoshi Yamashita.Klotho converts canonical FGF receptor into a specific receptor for FGF23[].Nature.2006
  • 6Kurosu, Hiroshi,Ogawa, Yasushi,Miyoshi, Masayoshi,Yamamoto, Masaya,Nandi, Animesh,Rosenblatt, Kevin P.,Baum, Michel G.,Schiavi, Susan,Hu, Ming-Chang,Moe, Orson W.,Kuro-o, Makoto.Regulation of fibroblast growth factor-23 signaling by Klotho[].Journal of Biological Chemistry.2006
  • 7Modem Suhasini,Hien Li,Suzanne M. Lohmann,Gerry R. Boss,Renate B. Pilz.Cyclic-GMP-Dependent Protein Kinase Inhibits the Ras/Mitogen-Activated Protein Kinase Pathway[].Molecular and Cellular Probes.1998
  • 8Sebolt-Leopold JS,Dudley DT,Herrera R,et al.Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo[].Nature Medicine.1999
  • 9Zou Y,Hu Y,Metzler B,et al.Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review)[].International Journal of Molecular Medicine.1998
  • 10Ben-Dov Iddo Z,Galitzer Hillel,Lavi-Moshayoff Vardit,Goetz Regina,Kuro-o Makoto,Mohammadi Moosa,Sirkis Roy,Naveh-Many Tally,Silver Justin.The parathyroid is a target organ for FGF23 in rats[].The Journal of Clinical Investigation.2007

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部